News

Clinical Research IO (CRIO) is a website and Android app that allows users to conducts trial visits on a tablet or desktop, design source online, manage and schedule subjects and communicate with study monitors remotely.

A new group of collaborators has formed to determine the benefits and risk tradeoffs Parkinson’s disease patients are willing to make for a potential new therapy. Dr. Brett Hauber of RTI Health Solutions spoke to us about the collaborative.

The Leukemia & Lymphoma Society (LLS) has selected myClin for its Acute Myeloid Leukemia (AML) clinical trial.

CluePoints announced a partnership with the Metrics Champion Consortium, an association that develops standardized performance metrics to improve clinical trials.

INC Research announces its involvement in the Leukemia & Lymphoma Society’s (LLS) precision medicine Master Trial for the treatment of acute myeloid leukemia (AML).

In 2014, EU Regulation n.536/2014 represented a significant step toward transparency of clinical trials in Europe. However, despite the EMA’s policy 0070, which reinforced this concept, several aspects remain to be determined or evaluated, leaving room for additional requirements and local interpretation.

eClinicalHealth Limited announced a partnership with Clinerion to offer a readiness certification to 27.5 million potential study candidates at hospitals in Turkey.

EUPATI celebrates its 5th Anniversary in Brussels by staging a free workshop.

The Drug Information Association (DIA) has released a video to introduce the two chairpersons of its 2017 EuroMeeting, to be held in Glasgow, U.K., from March 29-31

With pursuits in rare and orphan disease beginning to move more into the drug development mainstream, the opportunities and challenges in patient engagement and trial execution for these conditions are ever-evolving, as one strategy expert in the field discusses.

Medidata’s Clinical Cloud solution has been adopted by Japan’s Nobelpharma to power a clinical trial on sleep disorders in children with neurodevelopmental disabilities.

Schulman IRB will launch its new Central Oncology Review (COR) division this month.

FDA officials agree that large comparative clinical trials defeat the purpose of the abbreviated development program for biosimilars. Clinical testing is expected to gain market approval for most biosimilars, while emphasizing significant differences in developing biosimilars and innovator therapies.

The pharma and aerospace industries share similarities whereas both are highly regulated, risk adverse and fast-paced markets. However, if there’s one thing that pharma companies can learn from the aerospace industry, it’s their approach to operations.

CluePoints, a provider of RBM and CSM solutions for clinical trials, announced a new Data Quality Oversight service, RADAR.

KMR Group recently conducted its annual Clinical Trial Cycle Time Report.

Worldwide Clinical Trials has received findings from a recent global survey that evaluated preferences of investigators who participated in CNS studies that employ rater training and surveillance methodologies.